NCT04186520
- Conditions
- Central Nervous System Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +28 more
- Locations
-
- Medical College of Wisconsin and Froedtert Hospital Milwaukee, Wisconsin, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT05432635
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Recruiting
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
NCT05990465
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma, +23 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT06830759
- Conditions
- Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Hospital Britanico de Buenos Aires /ID# 274419 Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
- Hospital Universitario Austral /ID# 274393 Pilar, Buenos Aires, Argentina
- Instituto Alexander Fleming /ID# 277284 Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
- Hospital Privado Universitario De Córdoba /ID# 274457 Córdoba, Córdoba Province, Argentina
NCT04512716
- Conditions
- B ALL, B-ALL, DLBCL, +25 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
NCT04775745
- Conditions
- Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
- Locations
-
- Duke Univerisity Durham, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State University Columbus, Ohio, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +35 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT06517511
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Sun yat-sen university cancer center Guangzhou, Guangdong, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT07397832
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Tianjin Medical University Cancer Insititute & Hospital Tianjin, Tianjin Municipality, China
NCT05800405
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States